We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oramed Partners with ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule

News   Sep 18, 2008

 
Oramed Partners with ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule
 
 
 

RELATED ARTICLES

50% of Trial Subjects Who Took a Placebo Reported Suffering an Adverse Event

News

Research published today in Trials explores the negative effects that can be caused by participants being administered placebos in clinical trials, finding that half of people taking placebos reported side effects from the trial intervention.

READ MORE

Statins Have Low Risk of Side Effects

News

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.

READ MORE

Multigene Test Facilitates Targeted Use of Chemotherapy for Breast Cancer

News

New results show that the multigene test used at the university hospital in Munich is indeed helpful in making more targeted use of chemotherapy treatments and thus improves prognosis of breast cancer patients.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE